Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 8:19:101713.
doi: 10.1016/j.bonr.2023.101713. eCollection 2023 Dec.

Relationship between bone marrow adipose tissue and kidney function in postmenopausal women

Affiliations

Relationship between bone marrow adipose tissue and kidney function in postmenopausal women

Sammy Badr et al. Bone Rep. .

Abstract

Introduction: Bone marrow adipose tissue (BMAT) is associated with aging, osteoporosis, and chronic kidney disease (CKD). To date, the association between BMAT and kidney function in postmenopausal women has not been thoroughly investigated. The main purpose of this study was to determine whether a relationship exists between proton density fat fraction (PDFF) and kidney function in postmenopausal women.

Methods: We investigated the cross-sectional association between estimated glomerular filtration rate (eGFR) - calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation - and PDFF - measured at the lumbar spine and proximal femur using Water Fat Imaging (WFI) MRI - in 199 postmenopausal women from the ADIMOS cohort study. We also performed DXA scans and laboratory measurements of sclerostin and c-terminal Fibroblast Growth Factor 23 (cFGF23).

Results: Participants' mean age was 67.5 (standard deviation, SD 10.0) years. Their median eGFR was 85.0 (interquartile range, IQR 72.2-95.0) ml/min/1.73 cm2, and their mean lumbar spine PDFF was 57.9 % (SD 9.6). When classified by eGFR-based CKD stages, 41.7 % of the cohort had an eGFR ≥ 90 (n = 83), 47.2 % had an eGFR of 60-89.9 (n = 94), and 11.1 % had an eGFR of 30-59.9 (n = 22). Participants with eGFR ≥ 90 had a lower lumbar spine PDFF than those with eGFR 60-89.9 (mean 55.8 % (9.8) vs. 58.9 % (9.0), p = 0.031) and those with eGFR 30-59.9 (55.8 % (9.8) vs. 60.8 % (9.8), p = 0.043). However, the differences did not remain significant after adjusting for predetermined confounders, including age, diabetes, Charlson comorbidity index, recent history of fragility fracture, appendicular lean mass, and lumbar spine BMD. The inclusion of sclerostin and/or cFGF23 as suspected mediators did not alter the findings. When proximal hip imaging-based PDFF was considered, no significant differences were found between the eGFR categories in the unadjusted and adjusted analyses.

Conclusion: No evidence of an association between kidney function and bone marrow adiposity was found either in the lumbar spine or proximal femur in a cohort of postmenopausal women.

Keywords: Bone marrow adipose tissue; Bone mineral density; Chronic kidney disease; Estimated glomerular filtration rate; Osteoporosis.

PubMed Disclaimer

Conflict of interest statement

Anne Cotten has received an honorarium from Novartis. Bernard Cortet has received honoraria from Alexion, Amgen, Expanscience, Kyowa-Kirin, MSD, Novartis, Theramex, UCB and Viatris. Julien Paccou has received honoraria from Amgen, MSD, Eli Lilly, Kyowa-Kirin, Theramex and Pfizer. For the remaining authors, none were declared.

Figures

Fig. 1
Fig. 1
PDFF map of the lumbar spine computed from a multi-echo gradient echo sequence (mDixon-Quant) acquired in the sagittal plane in a 63-year old postmenopausal woman. The region of interest (green) was placed on the L1–L4 vertebral bodies. The mean PDFF value for this participant was calculated as the average of the L1–L4 segmented vertebrae measurements.
Fig. 2
Fig. 2
PDFF map of the non-dominant hip computed from a multi-echo gradient echo sequence (mDixon-Quant) acquired in the coronal plane (same patient as Fig. 1).

Similar articles

Cited by

References

    1. Beekman K.M., Duque G., Corsi A., Tencerova M., Bisschop P.H., Paccou J. Osteoporosis and bone marrow adipose tissue. Curr. Osteoporos. Rep. 2023;21:45–55. - PubMed
    1. Courtalin M., Bertheaume N., Badr S., During A., Lombardo D., Deken V., Cortet B., Clabaut A., Paccou J. Relationships between circulating sclerostin, bone marrow adiposity, other adipose deposits and lean mass in post-menopausal women. Int. J. Mol. Sci. 2023;24:5922. - PMC - PubMed
    1. Desbiens L.C., Sidibé A., Ung R.V., Mac-Way F. FGF23-klotho axis and fractures in patients without and with early CKD: a case-cohort analysis of CARTaGENE. J. Clin. Endocrinol. Metab. 2022;107:e2502–e2512. - PMC - PubMed
    1. Fairfield H., Falank C., Harris E., Demambro V., McDonald M., Pettit J.A., et al. The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis. J. Cell. Physiol. 2018;233:1156–1167. - PMC - PubMed
    1. Hernandez M.J., Dos Reis L.M., Marques I.D., Araujo M.J., Truyts C.A.M., Oliveira I.B., et al. The effect of vitamin D and zoledronic acid in bone marrow adiposity in kidney transplant patients: a post hoc analysis. PloS One. 2018;13 - PMC - PubMed